Caribou Biosciences to Participate in Citi’s 16Th Annual BioPharma Virtual Conference
01 sept. 2021 08h00 HE
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Sept. 01, 2021 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...